Sign In

Login

Password

Forgot Password ? Sign Up

Catecol O-metiltransferasa (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Catecol O-metiltransferasa" in Spanish language version.

refsWebsite
Global rank Spanish rank
18nih.gov
4th place
4th place
18doi.org
2nd place
2nd place
1frontiersin.org
4,679th place
1,565th place
1medwire-news.md
low place
low place

doi.org

dx.doi.org

  • Grossman MH, Emanuel BS, Budarf ML (abril de 1992). «Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2». Genomics 12 (4): 822-5. PMID 1572656. doi:10.1016/0888-7543(92)90316-K. 
  • Axelrod J (agosto de 1957). «O-Methylation of Epinephrine and Other Catechols in vitro and in vivo». Science 126 (3270): 400-1. PMID 13467217. doi:10.1126/science.126.3270.400. 
  • Matsumoto, M (2003). «Catechol O-methyltransferase mRNA expression in human and rat brain: Evidence for a role in cortical neuronal function». Neuroscience 116: 127. doi:10.1016/S0306-4522(02)00556-0. 
  • Karoum, Farouk; Chrapusta, Stanislaw J.; Egan, Michael F. (2002). «3-Methoxytyramine is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Simple T». Journal of Neurochemistry 63 (3): 972-9. PMID 7914228. doi:10.1046/j.1471-4159.1994.63030972.x. 
  • Ulmanen, Ismo; Peranen, Johan; Tenhunen, Jukka; Tilgmann, Carola; Karhunen, Tuula; Panula, Pertti; Bernasconi, Lilia; Aubry, Jean-Piere et al. (1997). «Expression and Intracellular Localization of Catechol O-methyltransferase in Transfected Mammalian Cells». European Journal of Biochemistry 243 (1–2): 452-9. PMID 9030772. doi:10.1111/j.1432-1033.1997.0452a.x. 
  • Stein MB, Fallin MD, Schork NJ, Gelernter J (noviembre de 2005). «COMT polymorphisms and anxiety-related personality traits». Neuropsychopharmacology 30 (11): 2092-102. PMID 15956988. doi:10.1038/sj.npp.1300787. 
  • Lotta T, Vidgren J, Tilgmann C, et al. (abril de 1995). «Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme». Biochemistry 34 (13): 4202-10. PMID 7703232. doi:10.1021/bi00013a008. 
  • Lachman HM, Morrow B, Shprintzen R, et al. (1996). «Association of codon 108/158 catechol-o-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.». American Journal of Medical Genetics 67 (5): 468-72. PMID 8886163. doi:10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G. 
  • Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM, Gilliam TC (diciembre de 2005). «Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations». Biol. Psychiatry 58 (11): 901-7. PMID 16043133. doi:10.1016/j.biopsych.2005.05.010. 
  • Robinson S, Goddard L, Dritschel B, Wisley M, Howlin P (2009). «Executive functions in children with autism spectrum disorders». Brain Cogn. 71: 362-368. PMC 3481002. PMID 19628325. doi:10.1016/j.bandc.2009.06.007. 
  • Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (mayo de 2005). «Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction». Biol. Psychiatry 57 (10): 1117-27. PMID 15866551. doi:10.1016/j.biopsych.2005.01.026. 
  • Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, Owen MJ (noviembre de 2007). «Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use». Br J Psychiatry 191: 402-7. PMID 17978319. doi:10.1192/bjp.bp.107.036129. Resumen divulgativo – MedWireNews. 
  • Lelli-Chiesa G, Kempton MJ, Jogia J, et al. (abril de 2011). «The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives». Psychol Med 41 (4): 779-88. PMID 20667170. doi:10.1017/S0033291710001431. 
  • Lelli-Chiesa G, Kempton MJ, Jogia J, Tatarelli R, Girardi P, Powell J, Collier DA, Frangou S (julio de 2010). «The impact of the Val158Met catechol- O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives». Psychol Med 41 (4): 1-10. PMID 20667170. doi:10.1017/S0033291710001431. 
  • Kempton MJ, Haldane M, Jogia J, Christodoulou T, Powell J, Collier D, Williams SC, Frangou S (abril de 2009). «The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study». Int. J. Neuropsychopharmacol. 12 (3): 371-81. PMID 18796186. doi:10.1017/S1461145708009395. 
  • Wichers M, Aguilera M, Kenis G, Krabbendam L, Myin-Germeys I, Jacobs N, Peeters F, Derom C, Vlietinck R, Mengelers R, Delespaul P, van Os J (diciembre de 2008). «The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life». Neuropsychopharmacology 33 (13): 3030-6. PMID 17687265. doi:10.1038/sj.npp.1301520. 
  • Cairns, BE (2010 May). «Pathophysiology of TMD pain--basic mechanisms and their implications for pharmacotherapy». Journal of oral rehabilitation 37 (6): 391-410. PMID 20337865. doi:10.1111/j.1365-2842.2010.02074.x. 
  • Bonifácio MJ, Palma PN, Almeida L, Soares-da-Silva P (2007). «Catechol-O-methyltransferase and its inhibitors in Parkinson's disease». CNS Drug Rev 13 (3): 352-79. PMID 17894650. doi:10.1111/j.1527-3458.2007.00020.x. 

frontiersin.org

medwire-news.md

  • Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, Owen MJ (noviembre de 2007). «Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use». Br J Psychiatry 191: 402-7. PMID 17978319. doi:10.1192/bjp.bp.107.036129. Resumen divulgativo – MedWireNews. 

nih.gov

ncbi.nlm.nih.gov

  • Grossman MH, Emanuel BS, Budarf ML (abril de 1992). «Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2». Genomics 12 (4): 822-5. PMID 1572656. doi:10.1016/0888-7543(92)90316-K. 
  • Tai CH, Wu RM (febrero de 2002). «Catechol-O-methyltransferase and Parkinson's disease». Acta Med. Okayama 56 (1): 1-6. PMID 11873938. 
  • Axelrod J (agosto de 1957). «O-Methylation of Epinephrine and Other Catechols in vitro and in vivo». Science 126 (3270): 400-1. PMID 13467217. doi:10.1126/science.126.3270.400. 
  • Karoum, Farouk; Chrapusta, Stanislaw J.; Egan, Michael F. (2002). «3-Methoxytyramine is the Major Metabolite of Released Dopamine in the Rat Frontal Cortex: Reassessment of the Effects of Antipsychotics on the Dynamics of Dopamine Release and Metabolism in the Frontal Cortex, Nucleus Accumbens, and Striatum by a Simple T». Journal of Neurochemistry 63 (3): 972-9. PMID 7914228. doi:10.1046/j.1471-4159.1994.63030972.x. 
  • Ulmanen, Ismo; Peranen, Johan; Tenhunen, Jukka; Tilgmann, Carola; Karhunen, Tuula; Panula, Pertti; Bernasconi, Lilia; Aubry, Jean-Piere et al. (1997). «Expression and Intracellular Localization of Catechol O-methyltransferase in Transfected Mammalian Cells». European Journal of Biochemistry 243 (1–2): 452-9. PMID 9030772. doi:10.1111/j.1432-1033.1997.0452a.x. 
  • Stein MB, Fallin MD, Schork NJ, Gelernter J (noviembre de 2005). «COMT polymorphisms and anxiety-related personality traits». Neuropsychopharmacology 30 (11): 2092-102. PMID 15956988. doi:10.1038/sj.npp.1300787. 
  • Lotta T, Vidgren J, Tilgmann C, et al. (abril de 1995). «Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme». Biochemistry 34 (13): 4202-10. PMID 7703232. doi:10.1021/bi00013a008. 
  • Lachman HM, Morrow B, Shprintzen R, et al. (1996). «Association of codon 108/158 catechol-o-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome.». American Journal of Medical Genetics 67 (5): 468-72. PMID 8886163. doi:10.1002/(SICI)1096-8628(19960920)67:5<468::AID-AJMG5>3.0.CO;2-G. 
  • Bruder GE, Keilp JG, Xu H, Shikhman M, Schori E, Gorman JM, Gilliam TC (diciembre de 2005). «Catechol-O-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations». Biol. Psychiatry 58 (11): 901-7. PMID 16043133. doi:10.1016/j.biopsych.2005.05.010. 
  • Robinson S, Goddard L, Dritschel B, Wisley M, Howlin P (2009). «Executive functions in children with autism spectrum disorders». Brain Cogn. 71: 362-368. PMC 3481002. PMID 19628325. doi:10.1016/j.bandc.2009.06.007. 
  • Caspi A, Moffitt TE, Cannon M, McClay J, Murray R, Harrington H, Taylor A, Arseneault L, Williams B, Braithwaite A, Poulton R, Craig IW (mayo de 2005). «Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction». Biol. Psychiatry 57 (10): 1117-27. PMID 15866551. doi:10.1016/j.biopsych.2005.01.026. 
  • Zammit S, Spurlock G, Williams H, Norton N, Williams N, O'Donovan MC, Owen MJ (noviembre de 2007). «Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use». Br J Psychiatry 191: 402-7. PMID 17978319. doi:10.1192/bjp.bp.107.036129. Resumen divulgativo – MedWireNews. 
  • Lelli-Chiesa G, Kempton MJ, Jogia J, et al. (abril de 2011). «The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives». Psychol Med 41 (4): 779-88. PMID 20667170. doi:10.1017/S0033291710001431. 
  • Lelli-Chiesa G, Kempton MJ, Jogia J, Tatarelli R, Girardi P, Powell J, Collier DA, Frangou S (julio de 2010). «The impact of the Val158Met catechol- O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives». Psychol Med 41 (4): 1-10. PMID 20667170. doi:10.1017/S0033291710001431. 
  • Kempton MJ, Haldane M, Jogia J, Christodoulou T, Powell J, Collier D, Williams SC, Frangou S (abril de 2009). «The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study». Int. J. Neuropsychopharmacol. 12 (3): 371-81. PMID 18796186. doi:10.1017/S1461145708009395. 
  • Wichers M, Aguilera M, Kenis G, Krabbendam L, Myin-Germeys I, Jacobs N, Peeters F, Derom C, Vlietinck R, Mengelers R, Delespaul P, van Os J (diciembre de 2008). «The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life». Neuropsychopharmacology 33 (13): 3030-6. PMID 17687265. doi:10.1038/sj.npp.1301520. 
  • Cairns, BE (2010 May). «Pathophysiology of TMD pain--basic mechanisms and their implications for pharmacotherapy». Journal of oral rehabilitation 37 (6): 391-410. PMID 20337865. doi:10.1111/j.1365-2842.2010.02074.x. 
  • Bonifácio MJ, Palma PN, Almeida L, Soares-da-Silva P (2007). «Catechol-O-methyltransferase and its inhibitors in Parkinson's disease». CNS Drug Rev 13 (3): 352-79. PMID 17894650. doi:10.1111/j.1527-3458.2007.00020.x.